Back to results
US 11,078,259 B2Granted
Methods and compositions for promoting thermogenic potential
AssigneeJoslin Diabetes Center, Inc.
InventorsYu-Hua Tseng, Matthew Lynes, Ruidan Xue
Life of this patent
Estimating the term…
Loading patent…
Loading patent…
AssigneeJoslin Diabetes Center, Inc.
InventorsYu-Hua Tseng, Matthew Lynes, Ruidan Xue
Estimating the term…
The invention provides methods and compositions relating to molecular targets identified as being capable of increasing or decreasing thermogenic potential in cells, including preadipocytes. Included in the invention are methods and compositions relating to inhibiting or suppressing the activity of an uncoupling protein 1 (UCP1) negative regulator, such as cardiac actin 1 (ACTC1), somatostatin receptor 1 (SSTR1), FAT atypical cadherin 1 (FAT1), and protein tyrosine phosphatase receptor type B (PTPRB). Also included in the invention are methods and compositions relating to activating a UCP1 positive regulator, such as phosphatidylinositol-3,4,5-triphosphate-dependent Rac exchange factor 1 (PREX1), cortactin binding protein 2 (CTTNBP2), doublesex and mab-3-related transcription factor-like family A1 (DMRTA1), and endothelin receptor type B (ENDRB). The invention also provides methods and compositions relating to enrichment of cells having thermogenic potential based on cell surface markers, e.g., CD29, identified as being predictive of such.
A method of promoting thermogenic capacity in a thermogenically competent cell, the method comprising contacting the thermogenically competent cell with either an activator of a uncoupling protein 1 (UCP1) positive regulator or a UCP1 positive regulator, such that thermogenic capacity is promoted, wherein the UCP1 positive regulator is selected from the group consisting of phosphatidylinositol-3,4,5-triphosphate-dependent Rac exchange factor 1 (PREX1), cortactin binding protein 2 (CTTNBP2), doublesex and mab-3-related transcription factor-like family A1 (DMRTA1) and endothelin receptor type B (EDNRB), or combinations thereof.
A method of treating a human subject having obesity, said method comprising administering a therapeutically effective amount of
A method of decreasing the weight of a human subject, said method comprising administering a therapeutically effective amount of
Dependencies are inferred from the claim text.